From: Multimodal evoked potentials for functional quantification and prognosis in multiple sclerosis
 | All patients | RR | P | RR versus P | |
---|---|---|---|---|---|
 | (n = 100) | (n = 90) | (n = 10) | p* | p** |
F/M ratio | 62/38 | 59/31 | 3/7 | 0.040 | 0.072 |
Age (yrs) | 39 (10) | 37 (9) | 53 (7) | <0.0001 | <0.0001 |
Disease duration (yrs) | 9 (8) | 8 (7) | 19 (11) | 0.0030 | NA |
EDSS (0.0–10.0) | 3.0 (1.2) | 2.8 (1.0) | 5.0 (0.83) | <0.0001 | <0.0001 |
Global EP score (/30) | 12.1 (7.6) | 11.2 (7.4) | 19.8 (5.4) | 0.0006 | 0.011 |
UL MEP score (/10) | 2.6 (3.0) | 2.3 (2.9) | 5.0 (3.3) | 0.0064 | 0.035 |
LL MEP score (/10) | 3.9 (3.4) | 3.5 (3.3) | 7.4 (2) | 0.0004 | 0.0057 |
LL SEP score (/10) | 4.7 (3.4) | 4.4 (3.4) | 7.5 (1.8) | 0.0047 | 0.020 |
VEP score (/10) | 4.2 (3.6) | 4.0 (3.5) | 6.1 (3.9) | 0.079 | 0.35 |